ADICET BIO
Adicet Bio is a biotechnology company engaged in the design and development of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.
ADICET BIO
Social Links:
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2014-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.adicetbio.com
Total Employee:
101+
Status:
Active
Contact:
650-503-9095
Email Addresses:
[email protected]
Total Funding:
243.63 M USD
Technology used in webpage:
Domain Not Resolving Google Maps Amazon IPv6 COVID-19 Mobile Optimized New Relic Akamai Hosted Comcast Drupal
Similar Organizations
Adnovate Clinical
Adnovate Clinical is a biotechnology industry.
AlphaThera
AlphaThera is a biotechnology industry.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Functional Biosciences
Functional Biosciences is a biotechnology industry firm.
Landmark Bio
Landmark Bio is a biotechnology industry.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
RAGE Biotech
RAGE Biotech is a biotechnology industry.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-01-27 | Applied Immune Technologies | Applied Immune Technologies acquired by Adicet Bio | N/A |
Investors List
Novartis Venture Fund
Novartis Venture Fund investment in Series B - Adicet Bio
Johnson & Johnson Robotics and Digital Solutions
Johnson & Johnson Robotics and Digital Solutions investment in Series B - Adicet Bio
OrbiMed
OrbiMed investment in Series B - Adicet Bio
Samsung Ventures
Samsung Ventures investment in Series B - Adicet Bio
Pontifax
Pontifax investment in Series B - Adicet Bio
Regeneron
Regeneron investment in Series B - Adicet Bio
Novartis Venture Fund
Novartis Venture Fund investment in Series A - Adicet Bio
OrbiMed
OrbiMed investment in Series A - Adicet Bio
Pontifax
Pontifax investment in Series A - Adicet Bio
Key Employee Changes
| Date | New article |
|---|---|
| 2022-11-29 | Adicet Bio Appoints Nancy Boman, M.D., Ph.D., as Senior Vice President and Chief Regulatory Officer |
Official Site Inspections
http://www.adicetbio.com Semrush global rank: 4.78 M Semrush visits lastest month: 1.89 K
- Host name: ec2-54-176-110-96.us-west-1.compute.amazonaws.com
- IP address: 54.176.110.96
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
More informations about "Adicet Bio"
Leadership and Board of Directors for Adicet Bio
Chen Schor is President and CEO of Adicet Bio, a leader in the field of gamma-delta CAR T cell therapies for the treatment of autoimmune diseases and cancer. With more than 25 years of …See details»
Adicet Bio | Gamma Delta T cells | Off the-shelf T cell …
Nov 29, 2024 Adicet is a biotechnology company engaged in the development of first-in-class off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases.See details»
Adicet Bio - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 650-503-9095 Adicet Bio is a biotechnology company engaged in the design and development of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases.See details»
Adicet Bio, Inc | LinkedIn
Adicet Bio, Inc | 8,887 followers on LinkedIn. At Adicet (Nasdaq: ACET), we are defined by our mission to deliver best-in-class gamma-delta T cell therapies for patients fighting autoimmune ...See details»
Adicet Bio Company Profile | Management and Employees List
SQL International Organization for Standardization . Python Python Software Foundation . Java Oracle . CSS World Wide Web Consortium . Enterprise Resource Planning ...See details»
Adicet Bio, Inc Overview | SignalHire Company Profile
Adicet Bio, Inc is a public company that has been in the industry for 10 years. The company currently specializes in the Biotechnology, Pharmaceuticals areas. The position of the …See details»
Adicet Bio: Contact Details, Revenue, Funding, Employees and …
Adicet is a biotechnology company focused on developing first-in-class off-the-shelf allogeneic gamma-delta T cell therapies for cancer and autoimmune diseases. Their innovative approach …See details»
Adicet Bio Appoints Lloyd Klickstein, M.D., Ph.D. to the Board of ...
Aug 19, 2024 REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Aug. 19, 2024-- Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing …See details»
Adicet Bio, Inc Information - RocketReach
Where is Adicet Bio, Inc based? Adicet Bio, Inc is based in Redwood City, California.See details»
Adicet Bio | ACET Stock Price, Company Overview & News - Forbes
Adicet Bio, Inc. is a biotechnology company, which engages in the design and development of off-the-shelf allogeneic gamma delta T cell therapies for cancerSee details»
Adicet Bio, Inc Company Overview, Contact Details & Competitors …
Adicet Bio Inc. launches preclinical data highlighting ADI-270. Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T …See details»
Adicet Bio Announces Formation of Scientific Advisory Board
Jul 15, 2021 MENLO PARK, Calif and BOSTON, July 15, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic …See details»
Adicet Bio - Craft
Oct 29, 2024 Adicet Bio has 5 employees across 2 locations and $24.99 m in annual revenue in FY 2022. See insights on Adicet Bio including office locations, competitors, revenue, …See details»
Adicet Bio - Overview, News & Similar companies | ZoomInfo.com
May 14, 2024 Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. …See details»
Adicet Bio offices | Redwood City, CA 94065 | Boston, MA 02116
[email protected] . Adicet Bio offices. 1000 Bridge Parkway Redwood City, CA 94065 650-503-9095. Adicet Bio offices. 131 Dartmouth Street, 3rd Floor Boston, MA 02116 . About. …See details»
Adicet Bio - Company Profile - Tracxn
Nov 27, 2024 Email ID: *****@adicetbio.com; Key Metrics. Total Funding. $156M in 4 rounds. Latest Funding Round. Post IPO, Feb 16, 2021, $15M. Investors. Orbimed & 17 more. …See details»
Adicet Bio Appoints Nick Harvey as Chief Financial Officer
MENLO PARK, Calif. and BOSTON, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma …See details»
Leadership and Board of Directors for Adicet Bio
Chen Schor is President and CEO of Adicet Bio, a leader in the field of gamma-delta CAR T cell therapies for the treatment of cancer. With more than 25 years of global biopharmaceutical …See details»
Adicet Bio to Participate in Upcoming Investor Conferences
Nov 1, 2024 Investors: Anne Bowdidge [email protected]. Janhavi Mohite Precision AQ 212-362-1200 [email protected]. Media: Kerry Beth Daly …See details»
Adicet Bio Appoints Julie Maltzman, M.D. as Chief Medical Officer
3 days ago [email protected]. Janhavi Mohite Precision AQ 212-362-1200 [email protected]. Media: Kerry Beth Daly [email protected]. Twitter; …See details»